Trump nominates White House health adviser Heidi Overton as FDA commissioner

President Donald Trump announced on Truth Social on Wednesday that he has nominated Dr. Heidi Overton to serve as the next Commissioner of the Food and Drug Administration. Overton, a physician with extensive experience in public health, currently serves as a senior domestic policy adviser on health matters in the White House. Her appointment follows a period of significant turnover at the FDA, during which several senior officials have resigned or been reassigned.

The agency has been described as “roiled” by the exodus of top staff, raising concerns about its capacity to oversee drug approvals, medical device regulation, and food safety standards. Overton’s background in clinical medicine and her role in shaping national health policy are seen as assets that could help restore stability and continuity within the FDA’s leadership. If confirmed by the Senate, she would assume responsibility for steering the agency’s regulatory agenda amid ongoing scrutiny over its decision‑making processes and workforce challenges.

The nomination is expected to prompt a Senate confirmation hearing, where Overton’s qualifications and policy positions will be examined. Her leadership will be closely watched by industry stakeholders, consumer advocacy groups, and health professionals as the FDA continues to navigate complex regulatory and public health issues.